Hepatic Artery Transfusion of NKG2D CAR-T Cells to Treat Patients With Previously Treated Liver Metastatic Colorectal Cancer: a Prospective, Multicenter Clinical Trial
Latest Information Update: 07 Feb 2024
At a glance
- Drugs Anti-NKG2D chimeric antigen receptor natural killer cell therapy-Hangzhou Cheetah Cell Therapeutics (Primary)
- Indications Adenocarcinoma; Colon cancer; Liver metastases; Rectal cancer
- Focus Adverse reactions
- 25 Feb 2022 New trial record